Medtronic Partners with Cardiac Design Labs to Introduce Advanced Heart Monitoring Technology in India

The Padma Rhythms ELR device, a combination of an external patch with advanced Holter capabilities, ensures accurate and insightful data for the monitoring period.

In a strategic move, India Medtronic Private Limited has collaborated with Bengaluru-based Cardiac Design Labs (CDL) to introduce and expand access to CDL's novel diagnostic technology, Padma Rhythms. 

Cardiovascular disease (CVD) remains the leading cause of death globally and in India. 

The collaboration aims to address heart rhythm disorders, a significant contributor to CVD-related fatalities in the country. This external loop recorder (ELR) patch is designed for comprehensive, long-term heart monitoring and diagnosis.

Highlighting the significance of remote monitoring in the rapidly growing space of cardiac diseases, Michael Blackwell, vice president and managing director of Medtronic India, said, "The inclusion of Padma Rhythms ELR patch provides us with an opportunity to serve more patients by expanding its reach across India."

The Padma Rhythms ELR device, a combination of an external patch with advanced Holter capabilities, ensures accurate and insightful data for the monitoring period. Developed and manufactured in India by CDL, it is powered by a first-of-its-kind connected platform for managing tests, data, algorithms, analysis, review, and reporting. 

Commenting on the same, Anand Madanagopal, founder and CEO at CDL, said, "The launch of Padma Rhythms marks the coming together of a decade of building an indigenous platform with a strong R&D focus and interplay of technologies that can bring a tectonic shift in prevailing cardiac monitoring approaches."

Founded in 2011 in Bangalore, CDL aims to provide efficient cardiac monitoring and diagnosis through intelligent systems. CDL's innovation includes wearables designed for use in sweat-inducing conditions, with dependable workflows and minimal interventions for device use. An automated data transfer mechanism allows real-time access to test management dashboards and full disclosures on-demand.

In a separate initiative, Medtronic India introduced the Symplicity Spyral renal denervation system as a solution for addressing high blood pressure. 

The company also collaborated with Qure.ai for advanced stroke management, aiming to improve patient outcomes through the efficient use of technology. This partnership aimed to provide comprehensive stroke care solutions, leveraging Medtronic's neuroscience expertise and Qure.ai's AI-enabled innovations.

Also, Medtronic India, in association with Fortis Escorts Heart Institute, launched the nationwide campaign 'Reset the Beat.' The campaign focuses on increasing awareness about sudden cardiac arrest (SCA) and cardiopulmonary resuscitation (CPR), with plans to extend its reach to leading hospitals across India.